-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Centessa Pharmaceuticals plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2019 to 2024.
- Centessa Pharmaceuticals plc Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $1.05M, a 8.22% decline year-over-year.
- Centessa Pharmaceuticals plc Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was $2.84M.
- Centessa Pharmaceuticals plc annual Income Tax Expense (Benefit) for 2024 was $2.84M.
- Centessa Pharmaceuticals plc annual Income Tax Expense (Benefit) for 2023 was -$25.1M, a 3254% decline from 2022.
- Centessa Pharmaceuticals plc annual Income Tax Expense (Benefit) for 2022 was -$747K, a 755% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)